Celularity Operating Income

Celularity (CELU) currently reports a operating income of $-61M as of December 2025. That compares with $-38M in the prior-year period — down 59.8% year over year. Use the charts on this page to explore Celularity's operating income history and peer comparisons.

Celularity's operating income decreased from $-38M to $-61M — a 59.8% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Celularity reported $-61M in operating income as of December 2025. That compares with $-38M in the prior-year period — down 59.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-61M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Celularity, and consider following CELU for alerts when major investors trade the stock.

Celularity is classified in the Healthcare sector. On operating income, it currently shows $-61M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CELU with unrelated industries.